Inhibition of cleavage of Moloney murine leukemia virus gag and env coded precursor polyproteins by cerulenin
- PMID: 3489314
- DOI: 10.1016/0042-6822(86)90441-1
Inhibition of cleavage of Moloney murine leukemia virus gag and env coded precursor polyproteins by cerulenin
Abstract
Cerulenin, an inhibitor of de novo fatty acid (and cholesterol) biosynthesis, has been shown to significantly decrease (greater than 75%) the amount of Moloney murine leukemia virus (MMuLV) released into the culture medium of chronically infected mouse fibroblasts (I. Katoh, Y. Yoshinaka, and R.B. Luftig, 1986, Virus Res., in press). In order to clarify the mechanism by which this decrease in virus production occurs, we analyzed the kinetics of gag and env coded protein synthesis in M-MuLV infected, cerulenin-treated cells by immunoprecipitation with monospecific antisera to p30, p12, p10, gp70, and p15(E). We found that in pulse (15 min-2 hr)-chase (0-4 hr) experiments the cleavage of not only Pr65gag to p30 and other gag coded proteins but Pr80env to gp70 and Pr15(E) as well, was greatly reduced by cerulenin treatment. Further, since the total amount of label in the Pr65gag and Pr80env bands remained about the same or was slightly decreased in 2-hr pulsed, cerulenin-treated cells, this suggests that cerulenin decreases virus production, in part, by inhibiting the cleavage of both precursor gag and env coded polyproteins during virus assembly and budding at the cell membrane. We also observed that at longer chase periods (4 hr), the effect of cerulenin could be partially overriden in that minor amounts of cleaved gag and env coded polyproteins were produced and assembled into virion particles. However, these particles contained abnormally large amounts of the uncleaved precursor Pr65gag, suggesting that maturation was incomplete. The above results suggest two independent, but not exclusive, possible mechanisms of cerulenin action to block M-MuLV production, viz. cerulenin decreases the pool of fatty acids, thereby inhibiting fatty acid acylation of Pr65gag, as well as Pr80env, and thus preventing the interaction between gag (the p15 antigenic determinant on Pr65gag) and env [the p15(E) antigenic determinant of Pr15(E)] coded gene products at the cell membrane needed for efficient virus assembly (M. Satake and R. B. Luftig, 1983, Virology 124, 259-273), and cerulenin inhibits one or more proteolytic enzymes responsible for the cleavage of Pr65gag and Pr80env.
Similar articles
-
The effect of cerulenin on the synthesis of the precursor gag polyprotein in defective murine leukemia and sarcoma virus producing cell lines.Virology. 1986 Oct 15;154(1):207-13. doi: 10.1016/0042-6822(86)90442-3. Virology. 1986. PMID: 3019002
-
Quantitative separation of murine leukemia virus proteins by reversed-phase high-pressure liquid chromatography reveals newly described gag and env cleavage products.J Virol. 1984 Nov;52(2):492-500. doi: 10.1128/JVI.52.2.492-500.1984. J Virol. 1984. PMID: 6333515 Free PMC article.
-
The effect of cerulenin on Moloney murine leukemia virus morphogenesis.Virus Res. 1986 Aug;5(2-3):265-76. doi: 10.1016/0168-1702(86)90023-7. Virus Res. 1986. PMID: 3765826
-
Structural and antigenic characterization of the proteins of human T-cell leukemia viruses and their relationships to the gene products of other retroviruses.Princess Takamatsu Symp. 1984;15:147-57. Princess Takamatsu Symp. 1984. PMID: 6100635 Review.
-
Synthesis, Assembly, and Processing of Viral Proteins.In: Coffin JM, Hughes SH, Varmus HE, editors. Retroviruses. Cold Spring Harbor (NY): Cold Spring Harbor Laboratory Press; 1997. In: Coffin JM, Hughes SH, Varmus HE, editors. Retroviruses. Cold Spring Harbor (NY): Cold Spring Harbor Laboratory Press; 1997. PMID: 21433349 Free Books & Documents. Review.
Cited by
-
Molecular cloning of a novel isolate of feline immunodeficiency virus biologically and genetically different from the original U.S. isolate.J Virol. 1991 Mar;65(3):1572-7. doi: 10.1128/JVI.65.3.1572-1577.1991. J Virol. 1991. PMID: 1847473 Free PMC article.
-
Production of infectious particles from defective human immunodeficiency virus type 1 (HIV-1)-producing cell clones by superinfection with infectious HIV-1.Arch Virol. 1991;116(1-4):143-58. doi: 10.1007/BF01319238. Arch Virol. 1991. PMID: 2001175
-
DMP 323, a nonpeptide cyclic urea inhibitor of human immunodeficiency virus (HIV) protease, specifically and persistently blocks intracellular processing of HIV gag polyprotein.Antimicrob Agents Chemother. 1994 Jul;38(7):1635-40. doi: 10.1128/AAC.38.7.1635. Antimicrob Agents Chemother. 1994. PMID: 7979297 Free PMC article.
-
Processing of the structural proteins of human immunodeficiency virus type 1 in the presence of monensin and cerulenin.Proc Natl Acad Sci U S A. 1988 Dec;85(23):9283-6. doi: 10.1073/pnas.85.23.9283. Proc Natl Acad Sci U S A. 1988. PMID: 3194424 Free PMC article.
-
Human immunodeficiency virus type 1 vif, vpr, and vpu mutants can produce persistently infected cells.Arch Virol. 1991;120(3-4):181-92. doi: 10.1007/BF01310474. Arch Virol. 1991. PMID: 1835572
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Other Literature Sources
Miscellaneous